Summary:
This research study is to determine the number of rare tumor cells is in the blood for patients with advanced-stage (stage III or stage IV) breast, lung, prostate, and or ovarian cancer.
Qualified Participants Must:
• 18 years or older
•
Medically diagnosed with stage III or IV breast, lung, prostate, and or ovarian cancer
Qualified Participants May Receive:
- $100 per clinical visit
- 1 blood sample every month for 6 months
- Ask your study team about transportation and home health services at no cost to you